Cargando…
iTRAQ-based proteomic analysis reveals potential regulatory networks in dust mite-related asthma treated with subcutaneous allergen immunotherapy
Asthma is one of the most common childhood chronic diseases worldwide. Subcutaneous immunotherapy (SCIT) is commonly used in the treatment of house dust mite (HDM)-related asthma in children. However, the therapeutic mechanism of SCIT in asthma remains unclear. The present study aimed to investigate...
Autores principales: | Bai, Jun, Zhong, Jia-Yong, Liao, Wang, Hu, Ruo, Chen, Liang, Wu, Xian-Jin, Liu, Shuang-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533450/ https://www.ncbi.nlm.nih.gov/pubmed/32901873 http://dx.doi.org/10.3892/mmr.2020.11472 |
Ejemplares similares
-
Variation in allergen content in sublingual allergen immunotherapy with house dust mites
por: Moreno Benítez, F., et al.
Publicado: (2015) -
Characteristics and management of sublingual allergen immunotherapy in children with allergic rhinitis and asthma induced by house dust mite allergens
por: Trebuchon, Florence, et al.
Publicado: (2014) -
Safety of Accelerated Schedules of Subcutaneous Allergen Immunotherapy with House Dust Mite Extract in Patients with Atopic Dermatitis
por: Kim, Myoung-Eun, et al.
Publicado: (2011) -
House Dust Mite Subcutaneous Immunotherapy and Lung Function Trajectory in Children and Adolescents with Asthma
por: Nogami, Kazutaka, et al.
Publicado: (2022) -
Update on House Dust Mite Allergen Avoidance Measures for Asthma
por: Zuiani, Chiara, et al.
Publicado: (2020)